Patents by Inventor Laurence Clary

Laurence Clary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds that modulate PPAR?-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
    Patent number: 7968560
    Abstract: Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.
    Type: Grant
    Filed: September 21, 2009
    Date of Patent: June 28, 2011
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Etienne Thoreau, Michel Rivier, Jerome Aubert, Laurent Chantalat, Johannes Voegel
  • 3-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereof
    Patent number: 7879907
    Abstract: Novel 3-phenylpropanoic acid compounds have the general formula (I) below: and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or lipid metabolism-related diseases), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: February 1, 2011
    Assignee: Galderma Research & Development
    Inventors: Jean-Guy Boiteau, Laurence Clary, Jean-Claude Pascal, Veronique Parnet
  • Biaromatic compound activators of PPAR? receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7863332
    Abstract: Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/or of diseases related to the metabolism of lipids) or, alternatively, in cosmetic compositions.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: January 4, 2011
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Jean-Guy Boiteau, Corinne Millois Barbuis
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7807669
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: October 5, 2010
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
    Publication number: 20100247468
    Abstract: Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.
    Type: Application
    Filed: September 21, 2009
    Publication date: September 30, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence Clary, Etienne Thoreau, Michel Rivier, Jerome Aubert, Laurent Chantalat, Johannes Voegel
  • NOVEL 3-PHENYLPROPANOIC COMPOUND ACTIVATORS OF RECEPTORS OF PPAR TYPE AND PHARMACEUTICAL/COSMETIC COMPOSITIONS COMPRISED THEREOF
    Publication number: 20100158843
    Abstract: Novel 3-phenylpropanoic acid compounds have the general formula (I) below: and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or lipid metabolism-related diseases), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: December 7, 2009
    Publication date: June 24, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Guy BOITEAU, Laurence Clary, Jean-Claude Pascal, Veronique Parnet
  • NOVEL 3-PHENYL ACRYLIC ACID COMPOUND ACTIVATORS OF TYPE PPAR RECEPTORS AND PHARMACEUTICAL/COSMETIC COMPOSITIONS COMPRISED THEREOF
    Publication number: 20100144884
    Abstract: Novel 3-phenyl acrylic acid compounds have the following general formula (I): and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, as well as in the field of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or into cosmetic compositions.
    Type: Application
    Filed: December 7, 2009
    Publication date: June 10, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Guy BOITEAU, Laurence CLARY, Jean-Claude PASCAL, Sandrine CHAMBON
  • METHODS OF MODULATING PPAR GAMMA-TYPE RECEPTORS
    Publication number: 20100099689
    Abstract: Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.
    Type: Application
    Filed: September 18, 2009
    Publication date: April 22, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence CLARY, Etienne Thoreau, Michel Rivier, Jerome Aubert, Laurent Chantalat, Johannes Voegel
  • Methods for activating PPAR gamma-type receptors
    Publication number: 20100035988
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: October 9, 2009
    Publication date: February 11, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Compounds that modulate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7625914
    Abstract: Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: December 1, 2009
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Etienne Thoreau, Michel Rivier, Jerome Aubert, Laurent Chantalat, Johannes Voegel
  • Biaromatic compounds which activate PPAR?-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7626054
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: November 3, 2006
    Date of Patent: December 1, 2009
    Assignee: Galderma Research & Development
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7582663
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: September 17, 2007
    Date of Patent: September 1, 2009
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • NOVEL BIAROMATIC COMPOUNDS WHICH ACTIVATE PPARY TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
    Publication number: 20090062340
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: November 6, 2008
    Publication date: March 5, 2009
    Applicant: Galderma Research & Development
    Inventors: LAURENCE CLARY, CLAIRE BOUIX-PETER, MICHEL RIVIER, PASCAL COLLETTE, ANDRE JOMARD
  • NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS
    Publication number: 20090012129
    Abstract: Novel biaromatic compounds that modulate peroxisome proliferator-activator receptors, known as PPAR, having the formula (I): are formulated into pharmaceutical compositions useful in human or veterinary medicine, or alternatively, in cosmetic compositions.
    Type: Application
    Filed: April 28, 2008
    Publication date: January 8, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Guy Boiteau, Laurence Clary, Laurent Chantalat, Michel Rivier
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7452878
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: November 18, 2008
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20080070957
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: September 17, 2007
    Publication date: March 20, 2008
    Applicant: Galderma Research & Development, S.N.C.
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20080027077
    Abstract: Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/of diseases related to the metabolism of lipids), or, alternatively, in cosmetic compositions.
    Type: Application
    Filed: May 21, 2007
    Publication date: January 31, 2008
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Guy Boiteau, Laurence Clary, Corinne Barbuis
  • Polycyclic compounds which modulate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7307078
    Abstract: Novel polycyclic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: December 11, 2007
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Pascal Collette, Michel Rivier, Andre Jomard
  • Biaromatic ligand activators of PPAR? receptors
    Patent number: 7294639
    Abstract: Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPAR? receptor, such biaromatic ligand having the structural formula (I): and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treating a wide variety of dermatological afflictions, and for preventing and/or treating the signs of aging and/or dry skin.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: November 13, 2007
    Assignee: Galderma Research & Development
    Inventors: Jean-Michel Bernardon, Laurence Clary, Eric Terranova
  • Biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7285568
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: May 24, 2005
    Date of Patent: October 23, 2007
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard